Skip to main content
Clinical Trials/NCT06799806
NCT06799806RecruitingNot Applicable

The Impact of the Therapeutic Virtual Reality Headset on Patient Anxiety in the Waiting Room Before Flexible Bronchoscopy in Vigil

Centre Hospitalier le Mans1 site in 1 country80 target enrollmentStarted: February 27, 2025Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Recruiting
Enrollment
80
Locations
1
Primary Endpoint
Anxiety assessment

Study Overview

Brief Summary

Bronchial fibroscopy is a frequently used procedure in the management of pneumology patients, and can be a source of anxiety, particularly while waiting for the examination.

Investigator's professional experience has shown us that many patients are anxious in the waiting room before a flexible bronchoscopy in vigile.

A great deal of research has been carried out into the use of virtual reality to reduce anxiety and pain during care but shortly before bronchoscopy. The innovative aspect is to target the patient's waiting time for the examination. Waiting is a highly anxiety-provoking time, and nurses play a vital role in supporting patients.

Study Design

Study Type
Interventional
Allocation
Na
Intervention Model
Single Group
Primary Purpose
Supportive Care
Masking
None

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Adult patients with no age or gender restrictions, seen on an outpatient basis at Le Mans Hospital.
  • •In whom bronchial fibroscopy is indicated.
  • •Person affiliated with or benefiting from a social security .
  • •Free, informed and written consent signed by the participant and the investigator (no later than the day of inclusion and before any examination required by the research).
  • •Patient able and willing to answer questionnaires

Exclusion Criteria

  • •Patient refusing to participate in research
  • •Patient who has already undergone bronchoscopy in vigil
  • •Patient premedicated for bronchial fibroscopy (anxiolytic, etc.)
  • •Patients with a history of epilepsy or psychiatric pathology
  • •Patient with vertigo
  • •Patient uncooperative, demented or unable to tolerate headgear.
  • •patient under guardianship or curatorship
  • •Patients suffering from blindness or deafness
  • •Patient with known significant intolerance to screens and/or virtual reality devices
  • •Pregnant, nursing or parturient women
  • •Unscheduled patients: emergencies, etc.
  • •Hospitalized patients

Arms & Interventions

virtual reality

Experimental

virtual reality headset

Intervention: virtual reality device (Device)

Outcomes

Primary Outcomes

Anxiety assessment

Time Frame: Immediately after intervention

Anxiety assessment is measured using a Numerical Rating Scale (NRS) from 0 to 10, supplemented by a self-assessment questionnaire before and after using the Therapeutic Virtual Reality Headset.

Secondary Outcomes

  • Assessment of bronchoscopy realisation and sample collection(Immediately after intervention)

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials